Innate lymphoid cells in the airways (Q27012728)

European Journal of Immunology

PubMed

published in

1 reference

1 reference

1 reference

1368-74

1 reference

The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling.

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Innate or adaptive immunity? The example of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Innate lymphoid cells: emerging insights in development, lineage relationships, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

New insights into the development of lymphoid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Systemically dispersed innate IL-13-expressing cells in type 2 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Lineage(-)Sca1+c-Kit(-)CD25+ cells are IL-33-responsive type 2 innate cells in the mouse bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Transcription factor RORα is critical for nuocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

The many paths to asthma: phenotype shaped by innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Insights into the initiation of type 2 immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

IL-13 overexpression predisposes to anaphylaxis following antigen sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Modulatory role for retinoid-related orphan receptor alpha in allergen-induced lung inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Pulmonary fibrosis: pathogenesis, etiology and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Enhanced susceptibility of staggerer (RORalphasg/sg) mice to lipopolysaccharide-induced lung inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

A large-scale, consortium-based genomewide association study of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Increased IL-33 expression by epithelial cells in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Recent advances in IL-22 biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Interleukin-17 is a negative regulator of established allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Dual Role of IL-22 in Allergic Airway Inflammation and its Cross-talk with IL-17A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

Critical role for IL-13 in the development of allergen-induced airway hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

7 January 2021

Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

7 January 2021

Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

7 January 2021

Interleukin-22 is a negative regulator of the allergic response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

7 January 2021

Reciprocal expression of IL-25 and IL-17A is important for allergic airways hyperreactivity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

7 January 2021

Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242425

7 January 2021

Identifiers

DOI

10.1002/EJI.201242425

0 references

PubMed publication ID

22678892

1 reference